menu
    • menu
    [{"orgOrder":0,"company":"Rochester General Hospital","sponsor":"Bausch Health | Rochester Skin Lymphoma Medical Group","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Fluocinonide","moa":"Glucocorticoid receptor","graph1":"Oncology","graph2":"Undisclosed","graph3":"Rochester General Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Rochester General Hospital \/ Bausch Health | Rochester Skin Lymphoma Medical Group","highestDevelopmentStatusID":"1","companyTruncated":"Rochester General Hospital \/ Bausch Health | Rochester Skin Lymphoma Medical Group"},{"orgOrder":0,"company":"Wake Forest University Health Sciences","sponsor":"MEDICIS PHARMACEUTICAL CORP","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"Fluocinonide","moa":"Glucocorticoid receptor","graph1":"Dermatology","graph2":"Phase IV","graph3":"Wake Forest University Health Sciences","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Wake Forest University Health Sciences \/ MEDICIS PHARMACEUTICAL CORP","highestDevelopmentStatusID":"11","companyTruncated":"Wake Forest University Health Sciences \/ MEDICIS PHARMACEUTICAL CORP"},{"orgOrder":0,"company":"Wake Forest University","sponsor":"MEDICIS PHARMACEUTICAL CORP","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Miscellaneous","year":"2011","type":"Inapplicable","leadProduct":"Fluocinonide","moa":"Glucocorticoid receptor","graph1":"Dermatology","graph2":"Phase II","graph3":"Wake Forest University","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Wake Forest University \/ MEDICIS PHARMACEUTICAL CORP","highestDevelopmentStatusID":"8","companyTruncated":"Wake Forest University \/ MEDICIS PHARMACEUTICAL CORP"}]

    Find Clinical Drug Pipeline Developments & Deals for Topsyn

    Menu

    Topsyn

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Rochester General Hospital

                            Country arrow
                            Aquaexpo
                            Not Confirmed

                            Rochester General Hospital

                            Country arrow
                            Aquaexpo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Fluocinonide

                            Therapeutic Area : Oncology

                            Study Phase : Undisclosed

                            Sponsor : Bausch Health | Rochester Skin Lymphoma Medical Group

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma

                            Details : Fluocinonide is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Mycosis Fungoides.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            November 26, 2014

                            Lead Product(s) : Fluocinonide

                            Therapeutic Area : Oncology

                            Highest Development Status : Undisclosed

                            Sponsor : Bausch Health | Rochester Skin Lymphoma Medical Group

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Wake Forest University

                            Country arrow
                            Aquaexpo
                            Not Confirmed

                            Wake Forest University

                            Country arrow
                            Aquaexpo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Fluocinonide

                            Therapeutic Area : Dermatology

                            Study Phase : Phase II

                            Sponsor : MEDICIS PHARMACEUTICAL CORP

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis

                            Details : Fluocinonide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dermatitis, Atopic.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            November 10, 2011

                            Lead Product(s) : Fluocinonide

                            Therapeutic Area : Dermatology

                            Highest Development Status : Phase II

                            Sponsor : MEDICIS PHARMACEUTICAL CORP

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Wake Forest University Health Sciences

                            Country arrow
                            Aquaexpo
                            Not Confirmed

                            Wake Forest University Health Sciences

                            Country arrow
                            Aquaexpo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Fluocinonide

                            Therapeutic Area : Dermatology

                            Study Phase : Phase IV

                            Sponsor : MEDICIS PHARMACEUTICAL CORP

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis

                            Details : Fluocinonide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dermatitis, Atopic.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            January 14, 2010

                            Lead Product(s) : Fluocinonide

                            Therapeutic Area : Dermatology

                            Highest Development Status : Phase IV

                            Sponsor : MEDICIS PHARMACEUTICAL CORP

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth